Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …

Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …

Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190
species of Mycobacterium. The clinical presentation for most NTM infections is non-specific …

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both
immunocompromised and immunocompetent patients. The incidence and prevalence of …

Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging infection
which is becoming increasingly prevalent, particularly in the elderly, for reasons which are …

Nontuberculous mycobacteria (NTM) are emerging pathogens that affect both
immunocompromised and immunocompetent patients. The development of molecular …

Non-tuberculous mycobacteria (NTM) include more than 160 ubiquitous, environmental,
acid-fast-staining bacterial species, some of which may cause disease in humans. Chronic …

Objective To accurately estimate the global prevalence of non-tuberculous mycobacteria
(NTM) in adults with non-cystic fibrosis (non-CF) bronchiectasis and to determine the …

Nontuberculous mycobacteria(NTM) have emerged as important pathogens in the setting of
cystic fibrosis (CF) lung disease. Although historically CF has been considered a fatal …

There are over 170 known species and subspecies of mycobacteria that have been
identified, and new species continue to be discovered (http://www. bacterio …